Revision in Remuneration of Managing Director - subject to shareholders approval

AMANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-4.7%1-day move

₹132.00

prior close

₹131.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1-1.9-1.5-2.3-4.7-1.5-0.8+1.3+0.2-8.3+12.6+21.6+24.7—

Up moveDown movePending

AI summary

The Board of Directors of Amanta Healthcare Ltd approved a revision in remuneration for Shri Bhavesh Girishbhai Patel, Chairman & Managing Director. His monthly remuneration will increase from ₹10,00,000 to ₹13,29,000 per month, effective April 1, 2026. This revision is subject to shareholder approval via Special Resolution at the upcoming Annual General Meeting. The increase represents approximately a 33% raise in monthly compensation. The board meeting was held on May 19, 2026, and lasted from 12:15 PM to 3:10 PM.

Likely market impact

This is a routine executive compensation revision requiring shareholder approval. The significant pay increase for the MD may attract shareholder scrutiny but is not unusual for growing companies. No immediate impact on stock price expected pending AGM approval.